ClinicalTrials.gg
CompletedNCT05163873ExPECTUpdated Apr 18, 2024

ExPECT: Extraperitoneal End Colostomy Trial

An interventional study of Extra-peritoneal in Colostomy Stoma, Cancer of Colon and Surgery, sponsored by Swansea Bay University Health Board. Completed at 3 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-18.

Sponsored by Swansea Bay University Health Board · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 107 studies in Colonic Neoplasms with a site in United Kingdom — 16 open to participants now, 25 under way, 6 of them phase 3. Colonic Neoplasms · United Kingdom.

Enrollment
71st of 80
23 · median 173
Started
2021
with 6 others
No phase
20 of 107
2 open now
Registered
86th of 107
by date

Among the 107 studies in Colonic Neoplasms with a site in United Kingdom, this one is the 71st largest by enrollment of the 80 interventional ones that give a count, is one of 7 that started in 2021, is one of 20 with no phase, and was the 86th registered.

Colonic Neoplasms

2,457 studies on the registry are indexed under Colonic Neoplasms; 456 are open to participants now.

Browse Colonic Neoplasms studies →

Open to participants now

16 of the 107 studies in Colonic Neoplasms with a site in United Kingdom are open now. Recruiting first, the newest first:

11 more — sign in →

All 16 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 326 Colonic Neoplasms studies recruiting now, 202 (62%) set no upper age limit and 72 (22%) stop at 75 or younger; 19 take children under 18; 35 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 107 studies in Colonic Neoplasms with a site in United Kingdom, or all of them as a file.
02

Study summary

A randomised controlled feasibility study to compare two surgery techniques in the formation of a permanent end colostomy; the trans-peritoneal(TP) technique - currently, the most commonly used technique and the investigational extra-peritoneal(EP) technique, which has been reported in small studies to reduce the risk of parastomal hernia . This feasibility study will primarily aim to determine the feasibility viability of progression to a full multi-centre trial and test study design acceptability for participants. Participants will be asked to consent to be randomised to either the TP or EP procedure during surgery. Following surgery, participants will be followed up to a maximum of 12 months and asked to complete quality of life questionnaires (EQ5D and Colostomy Impact Score). Participant data will also be accessed by research teams at site to collect data on stoma appliance use and complications.

Read the detailed description

This feasibility study is a multi-centre, single (patient) blinded, randomised controlled trial (RCT). Co-ordination and trial management will be led from Swansea Trials Unit (STU).

The study will take place across 3 sites: Swansea Bay University Health Board (SBUHB); Aneurin Bevan University Health Board and Cardiff and Vale University Health Board. Surgeons at all three sites have experience with both interventional extra-peritoneal surgical technique and the most commonly used transperitoneal technique.

The investigators aim to recruit 60 participants over 12 months. Local recruitment will be co-ordinated by PIs and research teams. Recruitment is aimed to be equally distributed across all sites. Participants will be equally randomised by arm in each of the three sites: to receive the EP colostomy formation (Intervention) or the standard transperitoneal (TP) technique. Participants will remain blinded as to their treatment until the close of the study.

Data collection will be performed by the clinical and research teams, with support from PIs. Data will be stored centrally in REDCap (Research Electronic Data Capture) software.

The investigators will explore whether it is possible to establish a research infrastructure in which data can be collected and co-ordinated across sites and for patients to be followed up effectively. The investigators will also look to demonstrate standardisation of the operative technique for EP stoma formation and to determine which outcome measures a future trial should explore. This feasibility trial be evaluated against ACCEPT progression criteria.

03

Conditions studied

  • Colostomy Stoma
  • Cancer of Colon
  • Surgery
  • Quality of Life

Keywords

  • colostomy
  • surgery
  • colon cancer
  • feasibility study
  • cancer
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years and over
  • Able and willing to give to participate
  • Elective patient for colorectal surgery requiring formation of permanent end colostomy (This may include patients undergoing surgery for rectal or anal cancer, inflammatory bowel disease, diverticular disease and functional bowel disorders)
  • Suitable to receive both trans-peritoneal and extra-peritoneal techniques

Exclusion criteria

Exclusion Criteria:

  • Lacking the capacity to consent
  • Having emergency surgery
  • Previous or current abdominal wall stoma
  • Intention to form loop colostomy, ileostomy or double-barrelled stoma
  • Previous incisional hernia repair with disruption of abdominal wall layers
  • Pregnant or breastfeeding (as determined by standard NHS procedures)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
23 participants (actual)

Study arms

  • No intervention
    Trans-peritoneal

    Surgery technique in the formation of permanent end colostomy

  • Experimental
    Extra-peritoneal

    Surgery technique in the formation of permanent end colostomy

    Procedure: Extra-peritoneal

Interventions

  • ProcedureExtra-peritoneal

    Surgery procedure: a non-mesh prophylactic surgical technique to prevent PH

06

What researchers measure

Primary outcomes

  1. Assessing the feasibility of the trial based on recruitment rate

    number of eligible patients who consent

    Time frame: Consent

  2. Assessing the feasibility of the trial based on data completeness

    % follow up data collected for 80% of participants

    Time frame: Week 6

  3. Assessing the feasibility of the trial based on surgeon involvement

    number of surgeons at sites willing to be involved in the trial

    Time frame: set up

  4. Assessing the feasibility of the trial based on recruitment within sites

    number of patients recruited at each site to be at least 10

    Time frame: consent

  5. Assessing the feasibility of the trial based on surgeon training

    ability to successfully train surgeons taking part

    Time frame: set up

  6. Assessing the feasibility of the trial based on surgeon compliance with the intervention

    80% compliance with the correct technique required

    Time frame: month 12

  7. Assessing the feasibility of the trial based on collection of key outcomes

    collection of colostomy impact score, EQ-5D and rate of parastomal hernia

    Time frame: week 6, month 6 and month 12

  8. Assessing the feasibility of the trial based on overall QoL reported in intervention group compared with standard care group

    QoL data to be 80% or more of that in the standard care group

    Time frame: week 6, month 6 and month 12

07

Study locations

3 sites
  • Cardiff and Vale University Health Board
    Cardiff, United Kingdom
  • Aneurin Bevan University Health Board
    Newport, United Kingdom
  • Swansea Bay University Health Board
    Swansea, United Kingdom
08

References and documents

Individual participant data

Plan to share: No — No current plan to share IPD but will discuss with study team if and/or when the request arises.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2021 to primary completion in Mar 2024, 27 months.

Of 382 non-industry interventional studies with no phase under Colonic Neoplasms, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 55. This study's 27 months is below that.

Counting every sponsor, half of 404 studies reached it within 30 months; a quarter within 16 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2021
First posted
Dec 20, 2021
StartActual
Dec 9, 2021
Primary completionActual
Mar 31, 2024
CompletionActual
Mar 31, 2024
Last update
Apr 18, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05163873
Lead sponsor
Swansea Bay University Health Board
Collaborators
Swansea University
Responsible party
Sponsor
First posted
Dec 20, 2021
Start date
Dec 9, 2021
Primary completion
Mar 31, 2024
Completion
Mar 31, 2024
Last update
Apr 18, 2024

Study contacts

Gregory Taylor
study director · Swansea Bay University Health Board

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion